CNY:PA:PA-HSBC MSCI China UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 6.166

Change

+0.02 (+0.33)%

Market Cap

USD 0.63B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.02 (+0.05%)

USD 63.50B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+2.30 (+0.41%)

USD 12.35B
WRD:PA HSBC ETFs Public Limited Compa..

+0.10 (+0.29%)

USD 10.45B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+0.03 (+0.01%)

USD 8.60B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+0.75 (+0.15%)

USD 8.46B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.37 (+0.38%)

USD 7.00B
HHH:PA HSBC ETFs Public Limited Compa..

+0.25 (+0.43%)

USD 6.90B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.06 (+0.31%)

USD 6.43B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.93 (+0.48%)

USD 5.51B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.31 (+0.19%)

USD 4.88B

ETFs Containing CNY:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.83% 74% C 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.83% 74% C 78% C+
Trailing 12 Months  
Capital Gain 10.24% 42% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.24% 42% F 59% D-
Trailing 5 Years  
Capital Gain -13.52% 12% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.52% 13% F 41% F
Average Annual (5 Year Horizon)  
Capital Gain -7.64% 6% D- 19% F
Dividend Return N/A 52% F 56% F
Total Return N/A 8% B- 7% C-
Risk Return Profile  
Volatility (Standard Deviation) N/A 71% C- 65% D
Risk Adjusted Return N/A 86% B+ 20% F
Market Capitalization 0.63B 72% C 73% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.